Pulmonary edema in cerebral malaria patients in Thailand.
Pulmonary edema is a serious complication of falciparum malaria that usually occurs in association with cerebral malaria, acute renal failure, high parasitemias, or delayed antimalarial treatment. From 1993 to 1996, 120 adult patients admitted to the intensive care unit of the Bangkok Hospital for Tropical Diseases were enrolled in a prospective study to assess the combination of artesunate and mefloquine for the treatment of cerebral malaria. Twenty-five patients (21%) presented with pulmonary edema and a majority developed complications in other organs as well, especially acute renal failure. In most patients (19 of 25), pulmonary edema was noted on the first day of admission and was associated with higher parasitemias and levels of acidemia, than in patients without pulmonary edema. Ten of the 25 patients diagnosed with pulmonary edema developed signs consistent with adult respiratory distress syndrome (ARDS). The mean central venous pressure when pulmonary edema was diagnosed was markedly lower in ARDS than in non-ARDS patients, supporting the argument that fluid imbalance is not essential for malaria-induced lung injury. Seven of 10 patients with ARDS died, 5 within 24 hours of admission, but there were no deaths in the 15 pulmonary edema patients without ARDS. Early diagnosis and prompt treatment remain important principles to reduce the morbidity and mortality associated with complicated falciparum malaria. This report emphasizes that ARDS, when concurrently occurs, is a poor prognostic clinical indicator in cerebral malaria.
Aursudkij
B
B
Division of Pulmonary Medicine, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand.
Wilairatana
P
P
Vannaphan
S
S
Walsh
D S
DS
Gordeux
V R
VR
Looareesuwan
S
S
D018806:APACHE; D000293:Adolescent; D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000627:therapeutic use; D037621:Artemisinins; D000077332:Artesunate; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D016779:Malaria, Cerebral / Q000145:classification / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D008297:Male; D015767:Mefloquine / Q000627:therapeutic use; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D011654:Pulmonary Edema / Q000150:complications* / Q000401:mortality; D012128:Respiratory Distress Syndrome / Q000209:etiology* / Q000401:mortality; D012717:Sesquiterpenes / Q000627:therapeutic use; D013785:Thailand
D000962:Antimalarials; D037621:Artemisinins; D012717:Sesquiterpenes; D000077332:Artesunate; D015767:Mefloquine